Immunophotonics is excited to share that Dr. Robert CG Martin II, M.D, PhD, PACS, who serves as Principal Investigator and National Coordinating Investigator at the University of Louisville for Immunophotonics’ Phase 2 clinical trial, will be presenting his IRE data at the Central Surgical Association 81st Annual Meeting taking place June 6 – 8, 2024, at the Seelbach Hilton, Louisville, KY.

Dr. Martin is presenting on June 6 at 9:10 am in the SCIENTIFIC SESSION I, Medallion Ballroom AB, titled “Enhancing Immunotherapeutic Effect by IP-001 and Irreversible Electroporation in a Mouse Oligometastatic Models of Pancreatic Adenocarcinoma,” learn how Immunophotonics continues to explore the ability of IP-001 to transform a routine interventional-oncology procedure into a systemic immunotherapy against cancer.